Watanabe, Kazuhiro <br/><br/>
Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial.  [electronic resource] 

 -  Circulation journal : official journal of the Japanese Circulation Society  Apr 2004 
 - 280-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1346-9843 
<br/><br/><label>Standard No.: </label>10.1253/circj.68.280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--therapeutic use<br/>Aspirin--administration & dosage<br/>Biomarkers<br/>Coronary Circulation<br/>Creatine Kinase--blood<br/>Creatine Kinase, MB Form<br/>Drug Therapy, Combination<br/>Electrocardiography<br/>Emergency Service, Hospital--statistics & numerical data<br/>Female<br/>Fibrinolysis<br/>Fibrinolytic Agents--administration & dosage<br/>Heparin--administration & dosage<br/>Hospitals, University--statistics & numerical data<br/>Humans<br/>Isoenzymes--blood<br/>Japan--epidemiology<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Myocardial Reperfusion--methods<br/>Patient Admission--statistics & numerical data<br/>Plasminogen Activators--administration & dosage<br/>Prospective Studies<br/>Recombinant Proteins--administration & dosage<br/>Risk Factors<br/>Stroke Volume<br/>Thrombolytic Therapy--statistics & numerical data<br/>Time Factors<br/>Tissue Plasminogen Activator--administration & dosage<br/>Treatment Outcome<br/>Troponin T--blood<br/>Urokinase-Type Plasminogen Activator--administration & dosage